Cancer Treatment Navigator
Helping to improve patient survival with emerging therapies
lung-cancer.jpg

Our Team

Where Science Meets Compassion

History

Dr. Hartmut Stecher, Ph.D., is the Principal Scientist and Founder of Cancer Treatment Navigator. This Oncology Healthcare Consulting Firm was formed by melding his interest in science and medicine with his drive to use that knowledge to help people. During Dr. Stecher’s academic research career, he studied processes in cell biology, signal transduction, and medical genetics – important biochemical research areas that help to understand the underlying molecular basis for cancer and how to develop targeted medicines. Dr. Stecher's work during his tenure at major biotechnology companies has focused on cancers of the prostate, ovaries, breast, soft tissue, as well as multiple myeloma and different lymphomas. The idea of developing Cancer Treatment Navigator is partially based on Dr. Stecher’s history of helping friends and family members over the years who have faced and coped with a cancer diagnosis. He would gather information and discuss the diagnosis and its implications with them, as well as research the best available treatment options for them. He provided these cancer patients with solid scientific input to better help them to make their own informed treatment decisions. This has been made possible due to Dr. Stecher's skills and passion to teach complex medical issues in easy to understand language. His detailed knowledge of cancer and history of working with respected experts in cancer research enabled him to optimally represent and support people in getting the best care for their illness. Through Cancer Treatment Navigator, Dr. Stecher feels fortunate to be able to take his passion for biomedical science and help more people who are confronted with cancer.

TRAINING & RESEARCH

  • Doctorate degree  (Ph.D., biochemistry) 
  • Masters degree (biochemistry, microbiology) 
  • Four years post-doctoral training as Senior Research Fellow at University of Washington Medical Center 
  • Multiple Publications in peer-reviewed scientific and medical journals 
  • Certified in Biomedical Regulatory Affairs (University of Washington) 
  • Certified in Clinical Trial Management (University of Washington)

EMPLOYMENT HISTORY

  • Staff Scientist at General Clinical Research Center, University of Washington Medical Center 
  • Scientist at Dendreon Corporation with a focus on immunotherapy for cancer
  • Clinical Science Liaison at Centocor (Johnson & Johnson) with a focus on immunology
  • Medical Director and Director of Clinical Communication at Ortho Biotech Canada (Johnson & Johnson) with a focus on prostate cancer, ovarian cancer & multiple myeloma
  • Senior Director and Head of Medical Affairs at Seattle Genetics with a focus on lymphoma

PROFESSIONAL MEMBERSHIPS

  • ASCO (American Society of Clinical Oncology)
  • AACR (American Association for Cancer Research)
  • ASH (American Society of Hematology)
  • ASGCT (American Society of Gene and Cell Therapy)
  • EHA (European Hematology Association)
 

Get in touch

Cancer Treatment Navigator strives to ease the burden of constant worries about what to do next. We work to provide a scientifically sound and promising list of options. During our initial consultation we will discuss your medical history, treatment preferences, and the scope of your goals. 

Book an appointment ▸

 

Our Dedicated Team

 
 

Strategic & Clinical Operations DIRECTOR

Danny Luong

Danny graduated from the University of Washington, Tacoma with a Bachelor’s degree in Environmental Science with a concentration in Biology. His research background includes genetic analysis and cell signaling pathways of biological systems - both hallmarks in the molecular biology of cancer. Given his understanding of how much our health is affected by factors outside of our control, i.e., the environment, heritable diseases, he joined Cancer Treatment Navigator to help deconstruct and reinterpret the exciting treatment options being made available for those battling cancer.

Education

UNIVERSITY OF WASHINGTON TACOMA
B.S., Environmental Science with a concentration in Biology

Activities & Affiliations

  • Northwest Metastatic Breast Cancer Conference, 2016/2017
  • West Coast Colorectal Cancer Symposium, 2016

Research Projects

  • The examination of metabolic pathways in glycolysis through sequencing GAPDH genes of plants native to the Pacific Northwest. 

 
 

CLINICAL SCIENTIST

Sherry Brutt

Sherry grew up in the Midwest and relocated to Seattle to expand her career in the science of oncology. She completed her schooling in Minnesota, earning a Bachelor’s degree in Cell and Molecular Biology at Winona State University and a Master’s degree in Healthcare Administration at Saint Mary’s University. She joined Cancer Treatment Navigator after 8 years working as a scientist in numerous laboratories, including the Mayo Clinic, the University of Minnesota, and most recently at Seattle Cancer Care Alliance.

Sherry's interest in collaborative and personalized healthcare extends into her role as a Clinical Scientist, as she is passionate about helping cancer patients along their path to finding the best potential treatment options.

 

Education

SAINT MARY'S UNIVERSITY OF MINNESOTA
M.A., Healthcare Administration

WINONA STATE UNIVERSITY
B.S., Cell & Molecular Biology and a minor in Biochemistry

Activities & Affiliations

  • American Society for Clinical Pathology (ASCP)
  • Qualification in Cytometry (QCYM)

Research Projects

  • The study of collaborative medicine in increasing the quality of patient care. 
 
 

 
 

Scientific Communications Strategist

Mahima Trivedi

Mahima started her career as a scientist in research and development in the Biotechnology industry. Scientific communications turned out be a passion and she transitioned from patents and publications to developing disease awareness, product communications and educational programs for physicians and patients. Prior to joining Cancer Treatment Navigator, Mahima was involved in bringing specialty therapeutics and diagnostics to market in areas such as Autoimmune diseases and Cancer. The difficulties encountered by patients in navigating complex treatment choices were apparent despite efforts by drug companies, hospitals and patient organizations. Rapid advancements in genetic sequencing, targeted therapeutics and immunotherapy, presented opportunity only to those that got the right help at the right time. Resolving misinformation and access issues, and the willingness to help on a case by case basis to deliver the promise of personalized medicine inspired her to join the Cancer Treatment Navigator.

 
 

Education

DEPAUL UNIVERSITY
MBA, Finance & Marketing

UNIVERSITY OF ILLINOIS
M.S., Biochemistry

Activities & Affiliations

  • San Antonio Breast Cancer Symposium (SABCS)
  • American Society of Clinical Oncology (ASCO)

Research Projects

  • Digital and social Media communications for cancer treatments.
 
 

 
 

Operations Manager

Peg Beurhaus

Peg graduated from Ohio University with a Bachelor's in Business Administration. She assisted with the start-up of Cancer Treatment Navigator and has stayed on as their Operations Manager. Her previous experience has included Executive Director for a large non-profit agency in Ohio, Fiscal Director for a Bellevue non-profit, and Office Manager for a Seattle law firm.

Education

OHIO UNIVERSITY
B.B.A., Business Administration with a major in Accounting

Activities & Affiliations

  • Association of Legal Administrators (ALA)
  • Puget Sound Association of Legal Administrators (PSALA)
  • Ohio Association of Community Action Agencies (OACAA)

Professional Projects

  • Assisted in the zoning reclassification of an old dormitory to office space through the state of Ohio.